Core Essence Orthopaedics Raises $11.5M in Series B Financing

Core Essence Orthopaedics, Inc., a Fort Washington, Penn.-based orthopaedic device company, has raised $11.5m in Series B financing.
The round was led by Baird Venture Partners with participation from existing investor NewSpring Health Capital, Robin Hood Ventures and other individual backers.
The company intends to use the funding to commercialize its soft tissue and skeletal repair devices.
Led by CEO and Chairman John Moran, Core Essence has developed a range of products targeting high-volume, sports medicine procedures involving soft tissue and skeletal repair of the extremities. The company’s products are designed to better enable surgeons to perform minimally invasive arthroscopic and endoscopic procedures.
In conjunction with the funding, Pete Shagory, Partner at Baird Venture Partners, joins the company’s board.

Join the discussion